The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Tubridy Karen L since 2015.
The trader's CIK number is 1589888.
At the time of the last reporting, Tubridy Karen L was the Chief Development Officer of Akebia Therapeutics, Inc.. (stock ticker symbol AKBA).
Also see all insider trading activities at Akebia Therapeutics, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2020 | AKBA | 0 | $0 | 3,454 | $30,049 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2016 | EBIO | 0 | $0 | 4,372 | $9,093 | 0 | $0 |
2015 | EBIO | 0 | $0 | 4,427 | $12,616 | 0 | $0 |
1. Akebia Therapeutics, Inc. (AKBA)
2. Eleven Biotherapeutics, Inc. (EBIO)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2020-02-28 | AKBA | Sale | 3,454 | 8.70 | 30,049 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2016-06-27 | EBIO | Sale | 4,372 | 2.08 | 9,093 |
2015-12-28 | EBIO | Sale | 4,427 | 2.85 | 12,616 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Tubridy Karen L (Chief Development Officer of Akebia Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.